News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WELCH DANIEL G
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Disposed of 411,000 options to buy
@ $2.6, valued at
$1.1M
Acquired 205,500 options to buy
@ $2.6, valued at
$534.3k
Acquired 205,500 options to buy
@ $2.6, valued at
$534.3k
|
|
| 06/09/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/02/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 2,044 shares
@ $0 |
|
| 05/17/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/16/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 1,864 shares
@ $200.02, valued at
$372.8k
Exercised 1,864 options to buy
@ $135.63, valued at
$252.8k
|
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 5,150 shares
@ $200.04, valued at
$1M
Sold 1,990 shares
@ $200.12, valued at
$398.2k
Sold 295 shares
@ $200.06, valued at
$59k
Sold 4,890 shares
@ $200.06, valued at
$978.3k
Sold 1,888 shares
@ $200.05, valued at
$377.7k
Sold 3,171 shares
@ $200.05, valued at
$634.4k
Sold 3,462 shares
@ $200.1, valued at
$692.7k
Sold 351 shares
@ $200.07, valued at
$70.2k
Sold 5,835 shares
@ $200.07, valued at
$1.2M
Exercised 1,990 options to buy
@ $56.77, valued at
$113k
Exercised 5,150 options to buy
@ $64.38, valued at
$331.6k
|
|
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 995 shares
@ $200.11, valued at
$199.1k
Sold 5,680 shares
@ $200.71, valued at
$1.1M
Sold 3,575 shares
@ $201.59, valued at
$720.7k
Sold 5 shares
@ $202.49, valued at
$1k
Sold 7,158 shares
@ $202.51, valued at
$1.4M
Sold 112 shares
@ $203.05, valued at
$22.7k
Sold 817 shares
@ $200.45, valued at
$163.8k
Sold 851 shares
@ $201.51, valued at
$171.5k
Sold 1,082 shares
@ $202.54, valued at
$219.1k
Sold 3,124 shares
@ $200.45, valued at
$626.2k
Sold 3,317 shares
@ $201.51, valued at
$668.4k
|
|
| 03/17/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 2,037 shares
@ $200.05, valued at
$407.5k
Sold 320 shares
@ $200.05, valued at
$64k
Sold 1,246 shares
@ $200.05, valued at
$249.3k
Exercised 2,037 options to buy
@ $38.82, valued at
$79.1k
|
|
| 03/16/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 283 shares
@ $202.36, valued at
$57.3k
Sold 1,348 shares
@ $201.53, valued at
$271.7k
Sold 7,629 shares
@ $200.3, valued at
$1.5M
Sold 2,098 shares
@ $200.2, valued at
$420k
Sold 214 shares
@ $201.53, valued at
$43.1k
Sold 44 shares
@ $202.35, valued at
$8.9k
Sold 74 shares
@ $200, valued at
$14.8k
Sold 470 shares
@ $200, valued at
$94k
Sold 5,758 shares
@ $200.06, valued at
$1.2M
Sold 8,210 shares
@ $200.2, valued at
$1.6M
Sold 808 shares
@ $201.53, valued at
$162.8k
|
|
| 02/09/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Converted 123,508 shares
@ $0
Converted 123,508 options to buy
@ $0 |
|
| 02/02/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/28/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 118,784 options to buy
@ $4.05, valued at
$481.1k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/02/2021 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 45,229 options to buy
@ $9.17, valued at
$414.7k
|
|
| 06/28/2021 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,145 shares
@ $0
Granted 4,125 options to buy
@ $93.2, valued at
$384.5k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 86,184 options to buy
@ $4.6, valued at
$396.4k
Granted 312,750 options to buy
@ $1.74, valued at
$544.2k
|
|
| 02/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/04/2020 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 8,750 shares
@ $168.24, valued at
$1.5M
Sold 8,750 shares
@ $167.34, valued at
$1.5M
Sold 7,982 shares
@ $166.7, valued at
$1.3M
Sold 9,518 shares
@ $165.72, valued at
$1.6M
Sold 14,500 shares
@ $165.06, valued at
$2.4M
Sold 9,250 shares
@ $164.61, valued at
$1.5M
Exercised 14,500 options to buy
@ $19.02, valued at
$275.8k
Exercised 7,982 options to buy
@ $20.06, valued at
$160.1k
Exercised 9,518 options to buy
@ $20.06, valued at
$190.9k
Exercised 8,750 options to buy
@ $34.25, valued at
$299.7k
Exercised 8,750 options to buy
@ $36.7, valued at
$321.1k
|
|
| 06/30/2020 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,550 shares
@ $0
Granted 4,250 options to buy
@ $76.58, valued at
$325.5k
|
|
| 06/01/2020 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 1,595 shares
@ $0
Granted 2,966 options to buy
@ $72.74, valued at
$215.7k
|
|
| 05/19/2020 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 1,335 shares
@ $0
Granted 3,171 options to buy
@ $160.33, valued at
$508.4k
|
|
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2020 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Exercised 17,500 options to buy
@ $12.76, valued at
$223.3k
|
|
| 06/21/2019 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 1,570 shares
@ $0
Granted 2,174 options to buy
@ $82.25, valued at
$178.8k
|
|
| 06/13/2019 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 5,000 options to buy
@ $58.74, valued at
$293.7k
|
|
|
|
|